[1]
Yuseptian, H., Fauzar and Kurniati, R. 2026. Omalizumab in Reducing Exacerbation Rate and Oral Corticosteroid Burden in Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis. Sriwijaya Journal of Internal Medicine. 4, 1 (May 2026), 16-29. DOI:https://doi.org/10.59345/sjim.v4i1.264.